Discovery and use ofT cell growth factor, interleukin 2 (IL-2), 1 have made it possible to immortalize functioning T cells and have facilitated studies on the activation, function, and antigen recognition of T cells (1-3). Human and murine neoplastic T cells secreting IL-2 have been particulary useful for the isolation and molecular characterization of IL-2 (4, 5).
Preparation of Conventional T Cell Factors. l X 106 purified peripheral T cells were stimulated with 0.1% protein phytohemagglutinin (PHA-P) for 48 h and partially purified by gel filtration on Sephadex G-100 in 0.5 M Nacl. Fractions of 15,000-25,000 mol wt were used, and the activity from 106 T cells was defined as 1 U.
Measurements ofBCGF, BCDF, and IL-2 Activities. BCGF activity was assessed by using anti-#-stimulated B cells or B cells recovered from PHA-induced B cell colonies. 5 × 104 nonadherent B cells in 0.2 ml medium (RPMI 1640 plus 10% FCS) were stimulated with 10 #g/ml of affinity-purified rabbit anti-human IgM coupled to Sepharose 4B in the presence or absence of varying concentrations ofcuhure supernatants from T hybridomas. After 4 d culture, cells were 3 3 pulsed with 1
#Ci of [ H]TdR for 5 h and the uptake of [ H]TdR was measured.
For the assessment of the activity of the supernatants to maintain the continuous growth of B cells, B cells from PHA-induced B colonies were used. The method of B cell colony formation was exactly the same as described (13) . 2 X 106 B cells in 2 ml McCoy's 5A modified medium with 15% FCS and 5 × 10 -5 M 2-mercaptoethanol were co-cultured with the same number of X-irradiated autologous T cells and stimulated with PHA-P (1 : 1,600). After 3 d liquid culture, cells were harvested and transferred to soft agar cultures with double layers as described previously (13) . After 7 d culture in soft agar, colonies were picked up and cells were pooled. 92% of pooled cells were positive for surface Ig by a direct immunofluorescent staining technique with fiuorescein isothiocyanate (FITC)-conjugated rabbit anti-human Ig (Behringwerke AG, Marburg, Federal Republic of Germany), and 3.5% of the cells formed SRBC rosettes. To remove T cells, the pooled cells (2 × 105) were treated with 100 #1 of the culture medium from anti-Leu-l-producing hybridomas, a gift of Dr. R. Evans (Memorial Sloan-Kettering Cancer Center, New York) and complement (1:4 diluted newborn rabbit serum). 1 X 103 B cells thus obtained from B colonies were incubated with 0.2 ml of supernatant from T hybrid clones for 3 d, and 0.5 #Ci [3H]TdR was pulsed for 6 h. All cultures were set up in triplicate.
BCDF activity in the supernatants was detected either by using CESS cells, which could differentiate into IgG-producing cells in the presence of BCDF (11), or Cowan I-stimulated normal B cells (14) . 1 X 104 CESS cells were incubated with 200 p~l of the supernatants from T hybridomas for 48 h and the number of IgG-producing cells was enumerated by reverse plaque assay using protein A-coupled SRBC and anti-y antiserum. BCDF activity for normal B cells was measured by using Cowan I-stimulated normal B cells. 1 × 106 purified B cells in 1 ml culture medium were stimulated with 0.0025% Staphylococcus aureus Cowan I (CalbiochemBehring Corp., La Jolla, CA). After 3 d culture, cells were harvested and 2 × 105 cells were cultured with 0.2 ml supernatants from T hybridomas for 2 d. IgG-producing cells were enumerated by reverse plaque assay.
Activity of IL-2 in the supernatants was measured by using an IL-2-dependent human cytotoxic T cell line as described previously (12) .
Results
THybridomas Secreting BCGF. Over I00 hybrid clones were established by hybridization of protein A-stimulated peripheral T cells with CEM-AG R and their culture 58.5 supernatants were tested for BCGF, BCDF, and IL-2 activities. As shown in Fig. 1 , culture supernatants from three hybrid clones, 77-A, 94-C, and 98-F, augmented the proliferation of anti-IgM-stimulated B cells. The activity of the supernatants was proportional to their concentrations, and the diluted (1:124) culture supernatant obtained from 10 e of 77-A cells showed BCGF activity comparable to that from 108 PHA-stimulated normal T cells, demonstrating that BCGF activity from 77 A cells was >100 times higher than that from PHA-stimulated normal T cells. The culture supernatants from the three hybrid clones, 77-A, 94-C, and 98-F, however, showed no IL-2 activity when tested with an IL-2-dependent human cytotoxic T cell line. Moreover, a hybrid clone 24-A, which had been shown to secrete IL-2 in our previous study (10) , did not show BCGF activity. Taken collectively, these results clearly show that the molecules distinct from IL-2 were involved in the proliferation of anti-Igactivated B cells. n.d.
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FIo. l. BCGF, BCDF, and IL-2 activity m the culture supernatants of human T hybrid clones. BCGF activity was assessed by using anti-g-stimulated human peripheral B cells or B cells recovered from PttA-induced B colonies. BCGF activity in the l:4-diluted culture supernatants is shown (mean ± SE of triplicate cultures). BCDF activity in the supernatants was detected by using either CESS cells or Cowan I-stimulated normal B cells. 
BCGF activity (%)
, • , v , v • | Ii , • n.d n.d I L-2 activity (%) g I I P BCDF activity (%) D 5o loo i , i | i • • • • i • • n.d F[o.
Discussion
The present study showed the successful establishment of human T hybridomas secreting monoclonal immunoregulatory molecules involved in the proliferation or differentiation of B cells. The presence of the B cell-specific growth factor distinct from IL-2 has been suggested in murine and human system (7, 8) . Howard et al. (8) demonstrated that a phorbol myristate acetate (PMA)-stimulated murine thymoma, EL-4, secreted BCGF that could be separated from IL-2 by molecular sieving or by absorption experiments. In the human system, discrepancies in the induction of proliferation of T and B cells in the culture supernatants of mitogen-stimulated T cells suggested the presence of the B cell-specific growth factor (7). More recently, absorption experiments (17) or chromatographical separation (18) have indicated that BCGF and IL-2 are different molecules. However, it has not yet been demonstrated that BCGF or BCDF without IL-2 is sufficient to induce proliferation or final differentiation of B cells, since monoclonal BCGF or BCDF preparations without IL-2 or other lymphokine activity have not yet been obtained. In this case, T hybridomas secreting monoclonal immunoregulatory molecules proved powerful tools, and the results herein clearly show that BCGF distinct from IL-2 or BCDF was present and could induce B cell proliferation without any contamination of IL-2.
Moreover, the present result with 77-A and 94-C cells showed the presence of the functional heterogeneity of BCGF and their synergism in the induction of B cell proliferation. In another experiment in our laboratory (19) , it was also demonstrated that an IL-2-dependent human helper T cell clone secreted BCGF with the molecular weight of 50,000, and this BCGF showed an synergistic effect, with the 20,000-mol wt-BCGF, on the proliferation of anti-g-stimulated B cells. These results indicate the presence of at least two different kinds of BCGF. At moment, the cellular or molecular mechanism of the synergism between the two BCGF is not known. A possibility is that one BCGF can act on B cells in Go phase and activate them into G1 phase, while another BCGF might push B cells in G1 phase into S phase. If this is the case, those BCGF with distinct functions will provide a powerful strategy for the establishment of nontransforming B cell lines.
Absorption experiments shown in Fig. 3 clearly demonstrated the strict specificity between T cell-derived factors and their target cells. IL-2-dependent T cells could absorb IL-2 activity but not BCGF activity, and BCGF activity was only absorbed with anti-/t-stimulated B cells, demonstrating the presence of the growth factor(s) specific for T or B cells. CESS cells, which may represent the final differentiation stage of B cells, could absorb BCDF but not BCGF activity, whereas anti-/t-stimulated B cells could not absorb BCDF activity, suggesting that acceptors for BCGF or BCDF may be expressed only in a certain activation stage of B cells. By the presence of such strict specificity between acceptors and factors and the temporal expression of acceptors, the specificity of the immune responses may be maintained even if they were regulated by antigen-nonspecific factors.
In the present experiments, both growth and differentiation factors for B cells were obtained from monoclonal T cell hybridomas. In our preliminary experiment, antiIg, BCGF, and BCDF from hybrid clones could induce Ig production in leukemic B cells, demonstrating that these three signals could induce proliferation and differentiation of a certain subset of B cells or B cells in a certain activation stage into Igproducing cells without help from MHC-restricted T cells. As our BCGF or BCDF did not have any IL-2 activity, we can analyze the direct effect of the factors on B cells without worrying about the contamination ofT cells in the B cell fraction. Thus, by using those monoclonal factors, we will be able to dissect the activation process of B cells and to analyze the signals required for each step of the activation process.
Summary
Human T hybridomas secreting B cell growth factors (BCGF) and B cell differentiation factor (BCDF) have been established. Hybrid clones 77-A, 94-C, and 98-F secreted BCGF that induced proliferation of anti-IgM-stimulated normal B cells. The culture supernatant from 77-A cells could also maintain continuous proliferation of colony-forming B cells, but the factor from 94-C could not. The addition of the supernatant from 94-C cells to that from 77-A cells, however, synergistically augmented the proliferation of colony-forming B cells, demonstrating the existence of two distinct kinds of BCGF and the synergism between them. These supernatants, however, showed no interleukin 2 (IL-2) or BCDF activity. A hybrid clone, 90-E, secreted BCDF. The culture supernatant induced Ig production in Cowan I-stimulated normal B cells or in a transformed B cell line, CESS. However, the supernatant had no BCGF or IL-2 activity. Anti-Ig-stimulated B cells, but not IL-2-dependent T cells, absorbed BCGF activity and CESS cells absorbed BCDF activity but not BCGF activity in the culture supernatants from T hybridomas. Taken collectively, the results demonstrated that IL-2, BCGF, and BCDF were different molecules and acceptors specific for the each molecule are present on the each target cell. 1 November 1982. 
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